Report Detail

Request for Sample of this report

Other Global Radiopharmaceuticals in Nuclear Medical Market Research Report 2019

  • RnM2716304
    • |
  • 14 April, 2020
    • |
  • Global
    • |
  • 119 Pages
    • |
  • QYResearch
    • |
  • Other

Global Radiopharmaceuticals in Nuclear Medical Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and also about each type from 2015 to 2026. This section mentions the volume of production by region from 2015 to 2026. Pricing analysis is included in the report according to each type from the year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2026.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Market Segment Analysis
The research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes

Segment by Application
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Industrial

Global Radiopharmaceuticals in Nuclear Medical Market: Regional Analysis
The report offers in-depth assessment of the growth and other aspects of the Radiopharmaceuticals in Nuclear Medical market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.
The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.
Global Radiopharmaceuticals in Nuclear Medical Market: Competitive Landscape
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.
The major players in the market include Bracco Imaging, Cambridge Isotope Laboratories, Cardinal Health, Medtronic, Eczacibasi-Monrol, Fujifilm Holdings Corporation, GE Healthcare (Subsidiary Of General Electric Company), IBA Group, Lantheus Medical Imaging, Nordion, Ntp Radioisotopes, Siemens Healthcare, Taiyo Nippon Sanso Corporation, Urenco Limited, Rotem Industries, etc.


Table of Contents

    1 Radiopharmaceuticals in Nuclear Medical Market Overview

    • 1.1 Product Overview and Scope of Radiopharmaceuticals in Nuclear Medical
    • 1.2 Radiopharmaceuticals in Nuclear Medical Segment by Type
      • 1.2.1 Global Radiopharmaceuticals in Nuclear Medical Production Growth Rate Comparison by Type 2020 VS 2026
      • 1.2.2 Diagnostic Radiopharmaceuticals
      • 1.2.3 Therapy Radiopharmaceuticals
      • 1.2.4 Enriched Stable Isotopes
    • 1.3 Radiopharmaceuticals in Nuclear Medical Segment by Application
      • 1.3.1 Radiopharmaceuticals in Nuclear Medical Consumption Comparison by Application: 2020 VS 2026
      • 1.3.2 Diagnostic Application
      • 1.3.3 Therapeutic Application
      • 1.3.4 Research
      • 1.3.5 Pharmaceutical
      • 1.3.6 Industrial
    • 1.4 Global Radiopharmaceuticals in Nuclear Medical Market by Region
      • 1.4.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Estimates and Forecasts by Region: 2020 VS 2026
      • 1.4.2 North America Estimates and Forecasts (2015-2026)
      • 1.4.3 Europe Estimates and Forecasts (2015-2026)
      • 1.4.4 China Estimates and Forecasts (2015-2026)
      • 1.4.5 Japan Estimates and Forecasts (2015-2026)
    • 1.5 Global Radiopharmaceuticals in Nuclear Medical Growth Prospects
      • 1.5.1 Global Radiopharmaceuticals in Nuclear Medical Revenue Estimates and Forecasts (2015-2026)
      • 1.5.2 Global Radiopharmaceuticals in Nuclear Medical Production Capacity Estimates and Forecasts (2015-2026)
      • 1.5.3 Global Radiopharmaceuticals in Nuclear Medical Production Estimates and Forecasts (2015-2026)

    2 Market Competition by Manufacturers

    • 2.1 Global Radiopharmaceuticals in Nuclear Medical Production Capacity Market Share by Manufacturers (2015-2020)
    • 2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Manufacturers (2015-2020)
    • 2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.4 Global Radiopharmaceuticals in Nuclear Medical Average Price by Manufacturers (2015-2020)
    • 2.5 Manufacturers Radiopharmaceuticals in Nuclear Medical Production Sites, Area Served, Product Types
    • 2.6 Radiopharmaceuticals in Nuclear Medical Market Competitive Situation and Trends
      • 2.6.1 Radiopharmaceuticals in Nuclear Medical Market Concentration Rate
      • 2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue
      • 2.6.3 Mergers & Acquisitions, Expansion

    3 Production Capacity by Region

    • 3.1 Global Production Capacity of Radiopharmaceuticals in Nuclear Medical Market Share by Regions (2015-2020)
    • 3.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Regions (2015-2020)
    • 3.3 Global Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 3.4 North America Radiopharmaceuticals in Nuclear Medical Production
      • 3.4.1 North America Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2015-2020)
      • 3.4.2 North America Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 3.5 Europe Radiopharmaceuticals in Nuclear Medical Production
      • 3.5.1 Europe Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2015-2020)
      • 3.5.2 Europe Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 3.6 China Radiopharmaceuticals in Nuclear Medical Production
      • 3.6.1 China Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2015-2020)
      • 3.6.2 China Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 3.7 Japan Radiopharmaceuticals in Nuclear Medical Production
      • 3.7.1 Japan Radiopharmaceuticals in Nuclear Medical Production Growth Rate (2015-2020)
      • 3.7.2 Japan Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)

    4 Global Radiopharmaceuticals in Nuclear Medical Consumption by Regions

    • 4.1 Global Radiopharmaceuticals in Nuclear Medical Consumption by Regions
      • 4.1.1 Global Radiopharmaceuticals in Nuclear Medical Consumption by Region
      • 4.1.2 Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Region
    • 4.2 North America
      • 4.2.1 North America Radiopharmaceuticals in Nuclear Medical Consumption by Countries
      • 4.2.2 U.S.
      • 4.2.3 Canada
    • 4.3 Europe
      • 4.3.1 Europe Radiopharmaceuticals in Nuclear Medical Consumption by Countries
      • 4.3.2 Germany
      • 4.3.3 France
      • 4.3.4 U.K.
      • 4.3.5 Italy
      • 4.3.6 Russia
    • 4.4 Asia Pacific
      • 4.4.1 Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption by Region
      • 4.4.2 China
      • 4.4.3 Japan
      • 4.4.4 South Korea
      • 4.4.5 Taiwan
      • 4.4.6 Southeast Asia
      • 4.4.7 India
      • 4.4.8 Australia
    • 4.5 Latin America
      • 4.5.1 Latin America Radiopharmaceuticals in Nuclear Medical Consumption by Countries
      • 4.5.2 Mexico
      • 4.5.3 Brazil

    5 Production, Revenue, Price Trend by Type

    • 5.1 Global Radiopharmaceuticals in Nuclear Medical Production Market Share by Type (2015-2020)
    • 5.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Type (2015-2020)
    • 5.3 Global Radiopharmaceuticals in Nuclear Medical Price by Type (2015-2020)
    • 5.4 Global Radiopharmaceuticals in Nuclear Medical Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    6 Global Radiopharmaceuticals in Nuclear Medical Market Analysis by Application

    • 6.1 Global Radiopharmaceuticals in Nuclear Medical Consumption Market Share by Application (2015-2020)
    • 6.2 Global Radiopharmaceuticals in Nuclear Medical Consumption Growth Rate by Application (2015-2020)

    7 Company Profiles and Key Figures in Radiopharmaceuticals in Nuclear Medical Business

    • 7.1 Bracco Imaging
      • 7.1.1 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
      • 7.1.2 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
      • 7.1.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
      • 7.1.4 Bracco Imaging Main Business and Markets Served
    • 7.2 Cambridge Isotope Laboratories
      • 7.2.1 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
      • 7.2.2 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
      • 7.2.3 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
      • 7.2.4 Cambridge Isotope Laboratories Main Business and Markets Served
    • 7.3 Cardinal Health
      • 7.3.1 Cardinal Health Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
      • 7.3.2 Cardinal Health Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
      • 7.3.3 Cardinal Health Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
      • 7.3.4 Cardinal Health Main Business and Markets Served
    • 7.4 Medtronic
      • 7.4.1 Medtronic Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
      • 7.4.2 Medtronic Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
      • 7.4.3 Medtronic Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
      • 7.4.4 Medtronic Main Business and Markets Served
    • 7.5 Eczacibasi-Monrol
      • 7.5.1 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
      • 7.5.2 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
      • 7.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
      • 7.5.4 Eczacibasi-Monrol Main Business and Markets Served
    • 7.6 Fujifilm Holdings Corporation
      • 7.6.1 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
      • 7.6.2 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
      • 7.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
      • 7.6.4 Fujifilm Holdings Corporation Main Business and Markets Served
    • 7.7 GE Healthcare (Subsidiary Of General Electric Company)
      • 7.7.1 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
      • 7.7.2 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
      • 7.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
      • 7.7.4 GE Healthcare (Subsidiary Of General Electric Company) Main Business and Markets Served
    • 7.8 IBA Group
      • 7.8.1 IBA Group Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
      • 7.8.2 IBA Group Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
      • 7.8.3 IBA Group Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
      • 7.8.4 IBA Group Main Business and Markets Served
    • 7.9 Lantheus Medical Imaging
      • 7.9.1 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
      • 7.9.2 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
      • 7.9.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
      • 7.9.4 Lantheus Medical Imaging Main Business and Markets Served
    • 7.10 Nordion
      • 7.10.1 Nordion Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
      • 7.10.2 Nordion Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
      • 7.10.3 Nordion Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
      • 7.10.4 Nordion Main Business and Markets Served
    • 7.11 Ntp Radioisotopes
      • 7.11.1 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
      • 7.11.2 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
      • 7.11.3 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
      • 7.11.4 Ntp Radioisotopes Main Business and Markets Served
    • 7.12 Siemens Healthcare
      • 7.12.1 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
      • 7.12.2 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
      • 7.12.3 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
      • 7.12.4 Siemens Healthcare Main Business and Markets Served
    • 7.13 Taiyo Nippon Sanso Corporation
      • 7.13.1 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
      • 7.13.2 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
      • 7.13.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
      • 7.13.4 Taiyo Nippon Sanso Corporation Main Business and Markets Served
    • 7.14 Urenco Limited
      • 7.14.1 Urenco Limited Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
      • 7.14.2 Urenco Limited Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
      • 7.14.3 Urenco Limited Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
      • 7.14.4 Urenco Limited Main Business and Markets Served
    • 7.15 Rotem Industries
      • 7.15.1 Rotem Industries Radiopharmaceuticals in Nuclear Medical Production Sites and Area Served
      • 7.15.2 Rotem Industries Radiopharmaceuticals in Nuclear Medical Product Introduction, Application and Specification
      • 7.15.3 Rotem Industries Radiopharmaceuticals in Nuclear Medical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
      • 7.15.4 Rotem Industries Main Business and Markets Served

    8 Radiopharmaceuticals in Nuclear Medical Manufacturing Cost Analysis

    • 8.1 Radiopharmaceuticals in Nuclear Medical Key Raw Materials Analysis
      • 8.1.1 Key Raw Materials
      • 8.1.2 Key Raw Materials Price Trend
      • 8.1.3 Key Suppliers of Raw Materials
    • 8.2 Proportion of Manufacturing Cost Structure
    • 8.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medical
    • 8.4 Radiopharmaceuticals in Nuclear Medical Industrial Chain Analysis

    9 Marketing Channel, Distributors and Customers

    • 9.1 Marketing Channel
    • 9.2 Radiopharmaceuticals in Nuclear Medical Distributors List
    • 9.3 Radiopharmaceuticals in Nuclear Medical Customers

    10 Market Dynamics

    • 10.1 Market Trends
    • 10.2 Opportunities and Drivers
    • 10.3 Challenges
    • 10.4 Porter's Five Forces Analysis

    11 Production and Supply Forecast

    • 11.1 Global Forecasted Production of Radiopharmaceuticals in Nuclear Medical (2021-2026)
    • 11.2 Global Forecasted Revenue of Radiopharmaceuticals in Nuclear Medical (2021-2026)
    • 11.3 Global Forecasted Price of Radiopharmaceuticals in Nuclear Medical (2021-2026)
    • 11.4 Global Radiopharmaceuticals in Nuclear Medical Production Forecast by Regions (2021-2026)
      • 11.4.1 North America Radiopharmaceuticals in Nuclear Medical Production, Revenue Forecast (2021-2026)
      • 11.4.2 Europe Radiopharmaceuticals in Nuclear Medical Production, Revenue Forecast (2021-2026)
      • 11.4.3 China Radiopharmaceuticals in Nuclear Medical Production, Revenue Forecast (2021-2026)
      • 11.4.4 Japan Radiopharmaceuticals in Nuclear Medical Production, Revenue Forecast (2021-2026)

    12 Consumption and Demand Forecast

    • 12.1 Global Forecasted and Consumption Demand Analysis of Radiopharmaceuticals in Nuclear Medical
    • 12.2 North America Forecasted Consumption of Radiopharmaceuticals in Nuclear Medical by Country
    • 12.3 Europe Market Forecasted Consumption of Radiopharmaceuticals in Nuclear Medical by Country
    • 12.4 Asia Pacific Market Forecasted Consumption of Radiopharmaceuticals in Nuclear Medical by Regions
    • 12.5 Latin America Forecasted Consumption of Radiopharmaceuticals in Nuclear Medical

    13 Forecast by Type and by Application (2021-2026)

    • 13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)
      • 13.1.1 Global Forecasted Production of Radiopharmaceuticals in Nuclear Medical by Type (2021-2026)
      • 13.1.2 Global Forecasted Revenue of Radiopharmaceuticals in Nuclear Medical by Type (2021-2026)
      • 13.1.2 Global Forecasted Price of Radiopharmaceuticals in Nuclear Medical by Type (2021-2026)
    • 13.2 Global Forecasted Consumption of Radiopharmaceuticals in Nuclear Medical by Application (2021-2026)

    14 Research Finding and Conclusion

      15 Methodology and Data Source

      • 15.1 Methodology/Research Approach
        • 15.1.1 Research Programs/Design
        • 15.1.2 Market Size Estimation
        • 15.1.3 Market Breakdown and Data Triangulation
      • 15.2 Data Source
        • 15.2.1 Secondary Sources
        • 15.2.2 Primary Sources
      • 15.3 Author List

      Summary:
      Get latest Market Research Reports on Radiopharmaceuticals in Nuclear Medical. Industry analysis & Market Report on Radiopharmaceuticals in Nuclear Medical is a syndicated market report, published as Global Radiopharmaceuticals in Nuclear Medical Market Research Report 2019. It is complete Research Study and Industry Analysis of Radiopharmaceuticals in Nuclear Medical market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$2,900.00
      		$4,350.00
      		$5,800.00
      		2,320.00
      		3,480.00
      		4,640.00
      		2,708.60
      		4,062.90
      		5,417.20
      		456,257.00
      		684,385.50
      		912,514.00
      		241,831.00
      		362,746.50
      		483,662.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo